World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
31273
World Ranking
17845
National Ranking
934

Overview

Günter U. Höglinger is affiliated with Ludwig Maximilian University of Munich in Germany. Their research primarily focuses on medicine, with significant work in neurology, physiology, radiology, nuclear medicine and imaging, molecular biology, and cellular and molecular neuroscience.

The scientist's work spans a range of topics including Parkinson's disease mechanisms and treatments, Alzheimer's disease research and treatments, neurological disorders and treatments, neurological diseases and metabolism, advanced neuroimaging techniques and applications, dementia and cognitive impairment research, and genetic neurodegenerative diseases.

Some of the recent notable papers include:

  • The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy (2022, Movement Disorders)
  • Distribution patterns of tau pathology in progressive supranuclear palsy (2020, Acta Neuropathologica)
  • A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria (2024, The Lancet Neurology)
  • Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy (2020, JAMA Neurology)
  • Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases (2021, Science Translational Medicine)

Frequent co-authors of Höglinger include Johannes Levin, Matthias Brendel, Carla Palleis, Nicolai Franzmeier, and Robert Perneczky. Collaboration with these researchers reflects ongoing interdisciplinary work within neurodegenerative disease research.

Höglinger has published extensively in several key venues, including Movement Disorders, Alzheimer's & Dementia, bioRxiv (Cold Spring Harbor Laboratory), Journal of Neurology, and European Journal of Nuclear Medicine and Molecular Imaging.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz

  • Dopamine depletion impairs precursor cell proliferation in Parkinson disease

    Günter U Höglinger;Pamela Rizk;Marie P Muriel;Charles Duyckaerts

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman

  • Distribution patterns of tau pathology in progressive supranuclear palsy

    Gabor G. Kovacs;Gabor G. Kovacs;Gabor G. Kovacs;Milica Jecmenica Lukic;Milica Jecmenica Lukic;David J. Irwin;Thomas Arzberger

  • Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.

    Günter U Höglinger;Günter U Höglinger;Jean Féger;Annick Prigent;Patrick P Michel

  • Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation

    Kirsten Ridder;Sascha Keller;Maria Dams;Anne-Kathleen Rupp

  • The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.

    Gesine Respondek;Gesine Respondek;Gesine Respondek;Maria Stamelou;Maria Stamelou;Carolin Kurz;Carolin Kurz;Leslie W Ferguson

  • Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

    Adam L Boxer;Jin-Tai Yu;Lawrence I Golbe;Irene Litvan

  • Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors

    Brahim Nait-Oumesmar;Nathalie Picard-Riera;Christophe Kerninon;Laurence Decker

  • Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

    Günter U. Höglinger;Géraldine Carrard;Patrick P. Michel;Fadia Medja

  • The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease

    Günter U. Höglinger;Joshua J. Breunig;Candan Depboylu;Caroline Rouaux

  • A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

    Eduardo Tolosa;Irene Litvan;Günter U. Höglinger;David Burn

  • Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe.

    Pierre Champy;Günter U. Höglinger;Jean Feger;Christophe Gleye

  • Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

    Adam L Boxer;Anthony E Lang;Murray Grossman;David Knopman

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Dopamine and adult neurogenesis.

    Andreas Borta;Günter U Höglinger

  • Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

    Francisco Ros-Bernal;Stéphane Hunot;Maria Trinidad Herrero;Sebastien Parnadeau

  • Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation

    Kirsten Ridder;Sascha Keller;Maria Dams;Anne-kathleen Rupp

Frequent Co-Authors

Wolfgang H. Oertel
Wolfgang H. Oertel Philipp University of Marburg
Maria Stamelou
Maria Stamelou Hygeia Hospital
Matthias Brendel
Matthias Brendel Ludwig-Maximilians-Universität München
Peter Bartenstein
Peter Bartenstein Ludwig-Maximilians-Universität München
Christian Haass
Christian Haass Ludwig-Maximilians-Universität München
Kai Bötzel
Kai Bötzel Ludwig-Maximilians-Universität München
Irene Litvan
Irene Litvan University of California, San Diego
Etienne C. Hirsch
Etienne C. Hirsch Sorbonne University
Robert Perneczky
Robert Perneczky Ludwig-Maximilians-Universität München
Ulrich Müller
Ulrich Müller Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several alternative online degree options and career pathways in the healthcare field to explore. Programs such as online nursing degrees can provide flexible learning opportunities and diverse career outcomes, especially for those who may not wish to pursue a traditional MD or DO route.

Advanced degrees like a phd in nursing open doors to leadership and research roles in healthcare and education. For registered nurses aiming to expand their qualifications, understanding the average cost of rn to bsn programs can help plan for affordable, accredited options.

Individuals from non-nursing backgrounds can also enter the field with entry level msn programs online, offering a fast-track to a master’s degree and advanced clinical roles. Prospective students seeking a less competitive application process can look into the easiest bsn program to get into to start their nursing career with confidence.

Exploring these online degree options allows for greater flexibility and can help you tailor your career path to meet your long-term goals in healthcare.

Best Scientists Citing Günter U. Höglinger

Trending Scientists